Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.
Metrics to compare | MNZO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMNZOPeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | −0.4x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.7x | 2.6x | |
Price / LTM Sales | 0.0x | 1.4x | 3.3x | |
Upside (Analyst Target) | 0.0% | 230.5% | 43.5% | |
Fair Value Upside | Unlock | 6.3% | 6.8% | Unlock |